Ehave, Inc. Announces KetaDASH for Ketamine Home Delivery and Purchase of Curedash Assets Post published:December 16, 2020 Post category:Press Release
Ehave’s Dashboard to Meet the Challenge of Electronic Health Records Security with BurstIQ Partnership Utilizing Blockchain Technology Post published:November 9, 2020 Post category:Press Release
Ehave Expands Its Psychedelic Mental Health Platform with Medchart, a Leader in Medical Record Software, as a Plugin to the Ehave Dashboard Post published:October 20, 2020 Post category:Press Release
Ehave Signs Licensing Agreement to Enhance its Telemedicine Platform Post published:September 4, 2020 Post category:Press Release
Ehave, Inc. Announces Psychedelic Retreats Through Its Mycotopia Therapy Subsidiary Post published:August 28, 2020 Post category:Press Release
Ehave Announces Plans to Accelerate the Monetization of its Proprietary Digital Health Platform Post published:August 24, 2020 Post category:Press Release
Ehave, Inc. Engages Legal Counsel for Dual Listing of its Common Stock on the Canadian Securities Exchange (CSE) Post published:June 9, 2020 Post category:Press Release
Ehave, Inc. To Acquire Mdlink The Largest Telemedicine Platform in The CARICOM Countries And To Launch Mdlink Mental Therapy along with Psychedelic Treatments To Address Mental Health Post published:June 2, 2020 Post category:Press Release
Ehave, Inc. Adds Adviser For Clinical Trials For Its Cognitive And Psychedelic Opportunities To Medical Advisory Board Post published:June 1, 2020 Post category:Press Release